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Hypertension in elderly patients with a kidney
transplant
Abstract
Introduction: A large number of patients today with terminal kidney
failure are elderly. For a small number of these patients a kidney transplant
is a possible method of treatment.
Aim: The goal of this work was to investigate the prevalence of hyper-
tension among kidney transplant patients above the age of 65 and to analyze
anti-hypertension therapy.
Methods: The investigation included 27 patients, 15 male and 12 fe-
male, above the age of 65 who received a kidney transplant. The average age
of the patients was 71.2±5.6 years. The average time spent on dialysis before
the transplant was 2.7±2.1 years. The amount of time that had passed since
the transplant was 6.6±4.6 years. The average values of creatinine were
135±38.2 mmol/L.
Results: Of the number of patients analyzed, 25 (93%) had hyperten-
sion. In the anti-hypertension therapy five (20%) patients were taking one
antihypertensive drug, 14 (56%) patients were taking two drugs and six
(24%) patients were taking three or more drugs. The most frequently taken
medicine was a calcium channel blocker (68%) and together angiotensin
receptor blockers (ARB) and ACE-inhibitors (44%;32%). Of the analyzed
patients, 13 (52%) achieved the target values for blood pressure.
Conclusion: From the data acquired we can conclude that prevalence of
hypertension in the elderly group of patients is very high. Also, in half of
these patients the target values for blood pressure were achieved. The most
frequently used antihypertensives among older patients were calcium chan-
nel blocker or ARB and ACE-inhibitors.
INTRODUCTION
Hypertension appears in a large number of patients after trans-plants of the kidney and other solid organs. Individual works
have evaluated the prevalence of hypertension after a transplant up to
90% patients (1, 2). In addition to the traditional risk factors, it is influ-
enced by factors related to the transplant itself. One of the most impor-
tant risk factors associated with a transplant is the influence of im-
munosuppressive therapy, especially cyclosporine, in addition to many
other causes, such as the reduced function of the transplanted kidney
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Arterial hypertension is frequent among elderly peo-
ple. The aging process itself is related to the increased ri-
gidity of the blood vessels and to reduced vascular elastici-
ty, which increases the frequency of elevated blood pres-
sure, especially systolic (8).
The last several decades have shown an increase in
the average lifespan of the population. An increasing
share is now made up of elderly people. According to the
1999 census, 17% of the population of Croatia was above
the age of 65 (9). A large number of patients with termi-
nal kidney failure who begin dialysis today are elderly.
According to data of the Croatia Register for the Replace-
ment of Kidney Functions, the median age of patients
who began dialysis treatment in 2009 was 67 years (10).
According to data from our center, the average age of pa-
tients who began dialysis treatment in recent years was as
much as 70 (11).
A great number of older patients who are being trea-
ted by one of the types of dialysis have numerous accom-
panying diseases; most frequently among them is cardio-
vascular disease (12). A higher age in the general popula-
tion by itself carried an increased risk of cardiovascular
disease. Because of this, a kidney transplant is possible
only among a small portion of elderly patients as a me-
thod of treating terminal kidney failure. With the ad-
vancement and accessibility of diagnostic and therapeu-
tic methods in recent years, there has been a growth in
the number of elderly patients waiting for a kidney trans-
plant (12, 13, 14).
The goal of this work was to investigate the frequency
of hypertension in patients with a kidney transplant older
than 65 and to analyze their anti-hypertension therapy.
SUBJECTS AND METHODS
Subjects
Twenty-seven patients older than 65 who received
transplants at the Clinical Hospital Center Rijeka were
included in the examination, 12 female (44.4%) and 15
male (55.6%). Their average was 71.2±5.6 years (from 65
to 88). The average amount of time on dialysis before a
transplant was 2.7±2.1 years. The average amount of
time that passed since a transplant was 6.6±4.6 years.
Eight patients (29.6%) had interstitial nephritis as the
primary kidney disease; 6 patients (22.5%) had polycy-
stic kidney disease; 5 patients (18.5%) had glomerulo-
nephritis; 4 (14.5%) had diabetic nephropathy, and 4
(14.5%) had other diseases (Table 1).
All of the patient received a cadaveric kidney transplant.
The average values of creatinine were 135.4±36.4
mmol/L (from 96 mmol/L to 241 mmol/L). Fourteen pa-
tients had creatinine lower than 120 mmol/L, and thir-
teen patients had a level higher than 120 mmol/L (rang-
ing from 141 mmol/L to 214 mmol/L). Average body mass
index (BMI) was 24.1±2.1 kg/m2.
Eighteen patients were receiving triple immunosup-
pressive therapy (corticosteroids, cyclosporine or tacro-
limus and mycophenolate mofetil or azathioprine). Nine
patients had double therapy. Of those, four patients had
corticosteroid and cyclosporine as an immunosuppre-
ssive therapy. Two patients were taking corticosteroid
and mycophenolate mofetil, while another two were tak-
ing corticosteroid and azathioprine, and one was taking
corticosteroid and sirolimus (Table 2).
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Abbrevations: cortico – corticosteroid, TAC – tacrolimus,
MMF – mycophenolate mofetil, Cyclo – cyclosporin, AZA –
azathioprine, Sir – sirolimus
Methods
We took as the criterion for defining arterial hyperten-
sion a systolic blood pressure greather than 140 mmHg
and a diastolic pressure greather than 90 mmHg or the
routine use of anti-hypertension therapy. Blood pressure
was measured with a standard mercury sphygmoma-
nometer during regular out-patient examinations. Im-
munosuppressive and anti-hypertensive therapy was per-
formed by nephrologists.
Statistical analysis
The aims of this study were primarly descriptive. The
clinical characteristics of the patients are presented as a
mean ± standard deviation.
RESULTS
Of the patients examined, 25 (93%) had hypertension.
Among all of them hypertension appeared in the first
year after a transplant.
Among the patients who had a serum creatinine level
higher than 120 mmol/L all had hypertension.
Five patients (20%) took one medicine; 14 (56%) took
two medicines; and six patients (24%) took three or more
medicines. In monotherapy the most frequently taken
medicine was an angiotensin converting enzyme (ACE)
inhibitor or angiotensin receptor blockers (ARB) or cal-
cium channel blockers (seven patients). The most fre-
quent combination in dual therapy was a combination of
ACE inhibitors or ARB and calcium channel blockers
(seven patients, 50%). The other combination in dual
therapy was a combination of ACE inhibitors or ARB
blockers with a beta blocker (two patients) and a diuretic
(two patients). Six patients (24%) took a combination of
three or more anti-hypertension medicines (Table 3). Correlation between immunosuppressive therapy and
number of antihypertensive drugs see Table 4.
If all anti-hypertension medicines are analyzed, then
the most frequently taken medicine was a calcium antag-
onist in 17 (68%) patients, an ARB in 11 (44%) patients,
an ACE inhibitor in eight (32%) patients, as well as a
beta blocker, while six (24%) patients were taking a di-
uretic (Figure 1). Also, all elderly patients with hyperten-
sion had a hypolipemic as well as acetylsalicylic acid.
Of the patients analyzed, 13 (52%) achieved the target
blood pressure of 140/90 mmHg, while nine (36%) achie-
ved a blood pressure of 130/80 mmHg.
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Dual therapy 14 (56%)
ARB or ACE inhibitors + calcium
channels blockers
ARB or ACEinhibitors + b-blockers
ARB or ACEinhibitors + diuretics







Triple therapy or more 6 (24%)
Abbrevations: ACE – angiotensin converting enzyme, ARB –
angiotensin receptor blockers
TABLE 4
Correlation between antihypertensive and immunosup-
















Triple therapy or more 1
Without hypertension 0











Triple therapy or more 0
Without hypertension 1
Cortico+Sir (N=1) Without hypertension 1
Abbrevations: Cortico – corticosteroid; TAC – tacrolimus,
MMF – mycophenolat mofetil, Cyclo – cyclosporin, AZA –




















Figure 1. The most frequently used drugs
DISCUSSION AND CONCLUSIONS
The purpose of this investigation was to establish the
frequency of hypertension in elderly kidney transplant
patients. Of those patients analyzed, almost all (93%)
had hypertension. According to numerous studies, the
frequency of hypertension among kidney transplant pa-
tients is very great (1, 2, 4). Elderly person also have a
high frequency of hypertension compared to the general
population (more than 50%) (8). Since our study ana-
lyzed elderly kidney transplant patients, this high per-
centage of patients with hypertension was to be expected.
Of course, in this group nonpharmacological mea-
sures for the regulation of blood pressure, such as the
limitations on salt intake, maintaining an adequate body
weight and physical activity, etc., were not enough. They
required antihypertension therapy that often included
more than one antihypertension drug. Only 20 % of the
patients took one drug in antihypertension therpy; 56%
of the patients were using two drug, and 24% of the pa-
tients were using three or more drug in anthypertension
therapy. Patients with triple immunosuppressive therapy,
which included kalcineurinske inhibitors often require
the treatment of hypertension with three or more drugs.
The optimal antihypertension therapy is difficult to
prescribe for transplant patients. It depends most fre-
quently on the values of the blood pressure, immunosup-
pression therapy, the functioning of the kidney trans-
plant, and on any accompanying diseases (1). The useful-
ness of antihypertension therapy in reducing blood pres-
sure and lowering cardiovascular mortality and morbid-
ity has also been shown among elderly patients with
elevated blood pressure in the general population (8).
The most frequently prescribed antihypertension me-
dicines among our patients were calcium channel blo-
ckers (68%). Vasoconstriction is one of the basic mecha-
nisms in the appearance of hypertension in transplant
patients and the positive effect of calcium channel blo-
ckers (15). on it is important in regulating blood pressure
in this group of patients. ACE inhibitors and ARB blo-
ckers were the next most frequently used medicines in
anti-hypertension therapy. Since this group of medicines
works on the renin-angiotensin system, it is today indis-
pensable in regulating blood pressure and is frequently
used by a large number of patients as the medicine of
choice in hypertension therapy. This group of medicines
has also been shown in several studies to be successful in
reducing blood pressure and cardiovascular mortality
and morbidity among elderly people and in transplant
patients (16). On the other hand, the possibility of caus-
ing hyperkalemia, anemia (17), and even a reduction of
glomerular filtration (18) to a certain extent limits their
use among elderly patients with a kidney transplant. We
must be cautious in introducing them into an antihyper-
tension therapy. Such patients required at the outset
more frequent check-ups not only of blood pressure but
also for laboratory findings. According to the clinical
guidelines do not exist the first choice antihypertensive
drug in this group of patients. The choice of antihyper-
tensive drug may be determined by the presence of post-
transplant complications and cmorbid disease (19, 20).
Arterial hypertension is a primary and independent
factor in cardiovascular risk. According to data from the
World Health Organization, it is the leading risk factor
for death in the world. Cardiovascular diseases are most
frequently the cause of death among dialysis patients,
more than 50% (21). Kidney transplant also have a very
high percentage of death from cardiovascular diseases.
According to the United States Renal Data System, 37%
of patients with a kidney transplant die from cardiovas-
cular disease (21). Of course, the percentage of deaths
from cardiovascular disease is higher in elderly trans-
plant patients. According to data from an earlier study of
our elderly transplant patients, cardiovascular disease
was the cause of death in 43.2% of the patients. Detection
of hypertension after a transplant and its adequate treat-
ment will help in reducing cardiovascular disease and
mortality in this group of patients (22).
Of the number of patients analyzed, half of them
achieved the targeted blood pressure of 140/90 mmHg. If
the target blood pressure of 130/80 mmHg is taken as a
criterion, which in this group patients is a desired and
recommended value, 36% of the patients achieved the
target blood pressure. We cannot conclude from this
work if the reason for this is the reduced compliance of
the patient as a consequence of taking a large number of
medicines and completely neglecting the recommended
therapy or if it involves a group of patients for whom it is
more difficult to achieve the target blood pressure. In Eu-
ropean countries achievement of the target blood pres-
sure is between 17 and 35% (24). According to a study
carried out in 2001, in Croatia the target blood pressure
was achieved in 19% of patients (25). Compared to this
data from the general population, we can be satisfied
with the target blood pressure achieved in the group of
older kidney transplant patients of almost 50%, or 36%.
From personal experience in working with this group of
patients, frequent and regular check-ups, very frequent
monitoring of the patient over many years by the same
specialist, and their confidence in the method of treat-
ment have contributed to this achievement.
Finally, we can conclude that the appearance of hy-
pertension in an group of elderly kidney transplant pa-
tients is almost unavoidable and that its treatment is vital
and can be partially successful. In selecting an antihy-
pertension therapy, we must not forget the two basic
goals in treating hypertension in this group of patients:
the reduction of cardiovascular risk and safeguarding the
functioning of the kidney transplant.
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